Javitt Jonathan C Insider Trades

Insider Trading History

Track insider trading activity for Javitt Jonathan C. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
NRX Pharmaceuticals
NRX Pharmaceuticals NRXP
10% owner, Chairman And Chief Scientist
Holding Value $506k 125,000 shares
Last Trade
Apr 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$216k 125,000 shares
$1.73
$4.05
NRX Pharmaceuticals- Warrants (24/05/2026)
NRX Pharmaceuticals- Warrants (24/05/2026) NRXPW
10% owner, Chairman And Chief Scientist
Holding Value $1.78k 125,000 shares
Last Trade
Apr 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.21k 125,000 shares
$0.07
$0.01
NRX Pharmaceuticals- Warrants (24/05/2026)
NRX Pharmaceuticals- Warrants (24/05/2026) NRXPW
10% owner, Chairman And Chief Scientist
Holding Value $1.2k 84,634 shares
Last Trade
Dec 17, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.19k 40,000 shares
$0.08
$0.01
NRX Pharmaceuticals
NRX Pharmaceuticals NRXP
10% owner, Chairman And Chief Scientist
Holding Value $343k 84,634 shares
Last Trade
Dec 17, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$65.6k 40,000 shares
$1.64
$4.05
NRX Pharmaceuticals
NRX Pharmaceuticals NRXP
10% owner, Chief Scientist
Holding Value $1.81M 446,332 shares
Last Trade
Aug 23, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$28.4k 100,000 shares
$0.28
$4.05
NRX Pharmaceuticals- Warrants (24/05/2026)
NRX Pharmaceuticals- Warrants (24/05/2026) NRXPW
10% owner, Chief Scientist
Holding Value $6.34k 446,332 shares
Last Trade
Aug 23, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$761k 100,000 shares
$7.61
$0.01
NRX Pharmaceuticals
NRX Pharmaceuticals NRXP
10% owner, Chief Scientist
Holding Value $1.4M 346,332 shares
Last Trade
Aug 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$64k 200,000 shares
$0.32
$4.05
NRX Pharmaceuticals- Warrants (24/05/2026)
NRX Pharmaceuticals- Warrants (24/05/2026) NRXPW
10% owner, Chief Scientist
Holding Value $4.92k 346,332 shares
Last Trade
Aug 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.52M 200,000 shares
$7.61
$0.01
NRX Pharmaceuticals- Warrants (24/05/2026)
NRX Pharmaceuticals- Warrants (24/05/2026) NRXPW
Director
Holding Value $183k 12,899,997 shares
Last Trade
Dec 07, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.04M 400,000 shares
$7.61
$0.01
NRX Pharmaceuticals
NRX Pharmaceuticals NRXP
Director
Holding Value $52.2M 12,899,997 shares
Last Trade
Dec 07, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$576k 400,000 shares
$1.44
$4.05
NRX Pharmaceuticals
NRX Pharmaceuticals NRXP
10% owner, Chief Scientist
Holding Value $593k 146,332 shares
Last Trade
Jun 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$114k 200,000 shares
$0.57
$4.05
NRX Pharmaceuticals- Warrants (24/05/2026)
NRX Pharmaceuticals- Warrants (24/05/2026) NRXPW
10% owner, Chief Scientist
Holding Value $2.08k 146,332 shares
Last Trade
Jun 01, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.52M 200,000 shares
$7.61
$0.01
NRX Pharmaceuticals
NRX Pharmaceuticals NRXP
10% owner, Chief Executive Officer
Holding Value $54.1M 13,348,997 shares
Last Trade
May 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$359M 14,817,329 shares
$24.25
$4.05
NRX Pharmaceuticals- Warrants (24/05/2026)
NRX Pharmaceuticals- Warrants (24/05/2026) NRXPW
10% owner, Chief Executive Officer
Holding Value $190k 13,348,997 shares
Last Trade
May 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117M 14,817,329 shares
$7.90
$0.01
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $739k 960,000 shares
Last Trade
Aug 27, 2008 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$60.7M 1,000,000 shares
$60.72
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $739k 960,000 shares
Last Trade
Aug 27, 2008 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.43M 40,000 shares
$60.72
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $0 0 shares
Last Trade
Aug 27, 2008 Sale (In The Money)Reported as In The Money on SEC Form 4.
$60.7M 1,000,000 shares
$60.72
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $770k 1,000,000 shares
Last Trade
Sep 06, 2007 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$202M 1,000,000 shares
$202.40
$0.77
Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics BCLI
Director
Holding Value $77k 100,000 shares
Last Trade
Aug 27, 2007 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.1M 100,000 shares
$191.15
$0.77
NextGen Healthcare
NextGen Healthcare NXGN
Director
Holding Value $193k 8,074 shares
Last Trade
Jun 17, 2005 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$23.94

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up